Lumora
www.lumora.co.ukLumora is an early stage biotechnology company developing the next generation of molecular diagnostics.
Its development strategy is to produce IVDs of improved performance, compared to existing products, but which are simpler to use and lower cost. In particularly, its focus is on the developing markets in disease management, where an increasing demand for high volume, low-cost diagnostics is anticipated.
Its founding technology offers a means to couple the sensitive detection of specific analytes, e.g. nucleic acids, proteins or small molecules, to a quantitative, real-time luminescent output. The use of luminescence instead of e.g. fluorescence, permits far simpler hardware platforms to be employed reducing both hardware and reagent costs.
The simplicity of this technology not only permits the development of a universal platform upon which one is able to detect a wide range of disparate molecules, but in a range of capacities from single-sample portable detectors to ultra high-throughput laboratory-based instruments.
Lumora was founded in 2002 by Laurence Tisi and Jim Murray, when it was spun-out from the Institute of Biotechnology at the University of Cambridge where extensive experience in bioluminescence and assay development has accumulated over the last decade.
Staff
 Laurence Tisi, PhD, Acting CEO and Co-FounderDr Laurence Tisi is a world-leading expert in bioluminescence and has applied his expertise to the development of Lumora's core technologies. He is a named inventor on several patents in bioluminescence and has many years experience in bioluminescence assay development but also extensive expertise in isothermal DNA amplification techniques. In 2002 he was presented with the Marlene Deluca prize for his research on firefly luciferase at the International Symposium of Chemiluminesence and Bioluminescence (ISBC), and in the same year co-founded Lumora with Prof. Jim Murray. |  Professor Jim Murray, Co-FounderJim Murray is currently Professor of Molecular Biotechnology at the University of Cambridge. He is author of over 75 research papers and 10 patents, and runs a research group of 18 scientists within the Institute of Biotechnology. He is a long-standing collaborator with the biotechnology industry and is also Academic Director of the Masters in Bioscience Enterprise course, established under the auspices of the Cambridge-MIT Institute (CMI) with the aim of spreading a greater entrepreneurial culture and understanding within the UK economy. This highly successful course delivers graduates of the highest calibre for recruitment by the biotechnology, pharmaceutical, and consultancy industries and by European and national governments. |
Contact details
Tennis Court Road
Cambridge
CB2 1QT, UK
Tel: +44 (0)1223 334016
Fax: +44 (0)1223 334162
